Dr. Ma. Rosario VC Lao OB GYN, Functional and Aesthetic Gynecology

18/11/2025

30 variety of plants (fruits & vegetables) a week for a healthy lifestyle.

18/11/2025

💜 Keep Moving for Menopausal Health

Following World Menopause Day 2025, we’re continuing to share key insights from the IMS White Paper, The Role of Lifestyle Medicine in Menopausal Health: A Review of Non-Pharmacologic Interventions (2025).

🛼Physical Activity and Menopause - one of the most effective ways to protect health, manage symptoms, and maintain quality of life during and after menopause.

💃Regular movement supports heart, bone, and metabolic health, eases symptoms such as hot flushes and night sweats, and helps improve sleep, mood, and resilience.

🤸‍♀️Even small amounts make a meaningful difference - the best exercise is the one you enjoy and can keep up regularly.

📄 Download this factsheet and the full collection at www.worldmenopauseday.com.

🌍 IMS resources are available in multiple languages, with more being added over the coming days for global accessibility.

📲 Follow for new resources and updates.
💜 Share this post to help more women and healthcare professionals access trusted, evidence-backed information.
🤝 If you’re a healthcare professional, join the IMS and be part of our global community: https://www.imsociety.org/membership/

13/11/2025

13/11/2025

IMS Statement: US HHS Revises Black Box Warning for Menopause Hormone Therapy

Secretary Kennedy of the United States Department of Health and Human Services (HHS) has announced the removal of certain sections of the black box warning from all menopause hormone therapies (MHT), including systemic and vaginal preparations. The black box warning noted increased risks of myocardial infarction, invasive breast cancer, pulmonary emboli, deep vein thrombosis, and dementia. HHS stated that it is working with companies to update language in product labelling to remove references to risks of cardiovascular disease, breast cancer, and probable dementia.

In principle, the International Menopause Society (IMS) supports and welcomes consideration of the removal of the black box warning, with appropriate scientific review. Currently that warning applies to all types, all routes of administration, in all individuals. IMS agrees with the removal of these warnings from vaginal estrogen products, given reliable evidence in the medical and scientific literature that the systemic levels of estrogen resulting from vaginal routes of administration and the associate risks are negligible.

However, IMS does not support the removal of all warnings from systemic forms of MHT. Systemic oral or transdermal MHT can increase cardiovascular risks, breast cancer and dementia in certain populations of women, particularly those who initiate hormone therapy at later ages, or who already have evidence of these conditions. For this reason, the IMS maintains that it is important that clinicians inform women of potential risks regardless of any changes to the black box warnings. Individualised weighing of pros and cons, guided by the evidence, should be the principle of prescribing MHT and alternatives in the menopause.

Many women suffer unnecessarily from menopause symptoms, and systemic MHT can be used safely and highly effectively for the treatment of vasomotor symptoms and genitourinary symptoms of menopause, while also preserving preserve bone health. The benefits of MHT outweigh the risks for perimenopausal and younger postmenopausal women with bothersome symptoms and who otherwise have no contraindications. IMS has published World Menopause Day White papers in 2024 on menopause and MHT,https://www.imsociety.org/wp-content/uploads/2024/09/Menopause-and-MHT-in-2024-addressing-the-key-controversies-an-International-Menopause-Society-White-Paper.pdf
and in 2025 on lifestyle medicine,https://www.imsociety.org/wp-content/uploads/2025/10/IMS-White-Paper-The-Role-of-Lifestyle-Medicine-in-Menopausal-Health-2025.pdf which outline our recommended key/core principles of menopause management.

Ultimately, our care of women should be led by the evidence; hence, the latest IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause have been developed from rigorous systematic reviews, and are now in press, endorsed by a number of national, regional and global organisations. These Recommendations will be available online by December 2025 via the IMS website and our journal, Climacteric.

Fundamentally, the IMS believes that the labelling for menopause products should reflect evidence-based guidelines of scientific societies like the IMS and the Menopause Society through a process involving expert representatives of those societies, and that women are best served when scientific societies, healthcare services and pharmaceutical companies disseminate lay language summaries of those evidence-based guidelines to women.

25/10/2025

🌸 Today marks the first-ever World POI Day - a new global awareness initiative shining a light on Premature Ovarian Insufficiency (POI), which affects around 4 in 100 women under 40.

The Daisy Network, a volunteer-led UK charity, plays a vital role in providing information, guidance, and peer support for women living with POI. As they celebrate 30 years of service, we recognise the impact of their work in breaking stigma and building community.

Find out more here: https://daisynetwork.org

IMS Past President Prof. Nick Panay and Climacteric Editor-in-Chief Dr. Tim Hillard, are both Patrons of Daisy Network, whose continued advocacy is helping improve awareness, diagnosis, and care for women with POI.

For healthcare professionals looking for evidence-based resources and guidance see:

📘 2024 POI Guideline
Developed through a global collaboration between CRE-WHiRL, ESHRE, ASRM, and the International Menopause Society, this comprehensive guideline includes 145 evidence-based recommendations to optimise the diagnosis and management of POI.
📖 Read more in Climacteric, the official journal of the International Menopause Society: https://lnkd.in/eJ6x8Zc8

🎥 IMS Webinar: The New POI Guideline - What You Need to Know
Featuring Prof. Nick Panay and Prof. Richard Anderson, moderated by Prof. Wendy Wolfman, this webinar explores the key updates in the new guideline — from epidemiology and causes to fertility, pregnancy, and management.
📺 Free to watch via our website or YouTube channel: https://lnkd.in/e_Bx7ntT

25/10/2025

🌟 Lifestyle Medicine Webinar - Recording Now Available! 🌟

If you missed our recent IMS webinar for World Menopause Day 2025, you can now catch up on the full recording - available via the IMS website and our YouTube channel.

🎥 Featuring:
🔹 Dr. Chika Anekwe, lead author of the IMS White Paper The Role of Lifestyle Medicine in Menopausal Health: A Review of Non-Pharmacologic Interventions (2025)
🔹 Prof. Rossella Nappi, IMS President – Lifestyle medicine: A must-have in the menopause toolkit
🔹 Moderated by Prof. Ludwig Kiesel

💡 This session explores how lifestyle approaches from physical activity and nutrition to stress management and sleep, can support health and wellbeing during menopause.

📺 Watch now: available on the IMS website and YouTube: https://youtu.be/gVmAw8MJiU0
📲 Follow for expert-led webinars, symposia and resources
🤝 Become an IMS member and join our global community of menopause experts: https://www.imsociety.org/membership/

23/10/2025

18/10/2025

💜 Today is the Day! 💜
Happy World Menopause Day 2025! 🎉

This year’s theme is Lifestyle Medicine, framing menopause as a natural life transition while recognising the symptoms and health risks that call for personalised, holistic care that can be championed by the healthcare community.

Despite proven therapies that ease symptoms, protect health, and improve quality of life, millions of women still face stigma, misinformation, and barriers to care.

The IMS stresses women deserve the right to the support and materials that do exist, and that they reach those who need them.

The way forward lies in collaboration with healthcare providers, policymakers, and women themselves working together to make menopause support consistent, evidence-based, and universally accessible.

Clinicians are uniquely placed to normalise conversations, break taboos, and deliver the personalised care women urgently need. As the gateway to reliable information and consistent care, healthcare providers have the power to challenge stigma and misinformation, ensuring that no woman is left behind.

By working alongside healthcare professionals globally, IMS believes every woman, everywhere, can gain access to equitable, high-quality menopause care and that World Menopause Day 2025 marks the beginning of a universal standard of care.

📄 Explore the IMS White Paper, six Lifestyle Medicine Factsheets, plus new infographics and posters - all available now at worldmenopauseday.com

📢 Help us reach more women and healthcare professionals to have access to trusted, evidence-based menopause information:
✨ Share this post
✨ Follow
✨ Use

Together, we can make menopause care inclusive, evidence-based, and accessible for all women - everywhere. 💜

18/10/2025

Insomnia in Midlife

18/10/2025

💚 World Menopause Day 2025 💚
This year, the International Menopause Society shines a spotlight on Lifestyle Medicine in Menopause Care - highlighting the convincing evidence that lifestyle approaches can play a vital role in supporting health and wellbeing during and after menopause.

“Menopause is not a disease, but it can bring symptoms and health risks that need personalised care.”
— Prof. Rossella Nappi, President, International Menopause Society

The recently released IMS White Paper, The Role of Lifestyle Medicine in Menopausal Health: A Review of Non-Pharmacologic Interventions (2025), and six accompanying Lifestyle Medicine Factsheets explore practical, evidence-based ways to support women’s health through nutrition, activity, sleep, emotional wellbeing, and social connection.

📄 Discover the full White Paper and Factsheets at worldmenopauseday.com